<DOC>
	<DOCNO>NCT00878527</DOCNO>
	<brief_summary>The purpose study demonstrate safety functionality CircuLite Synergy Pocket Circulatory Assist Device .</brief_summary>
	<brief_title>Safety Performance Evaluation CircuLite Synergy</brief_title>
	<detailed_description>The CircuLite Synergy Pocket Circulatory Assist Device implantable miniature , mixed-flow blood pump design provide partial leave ventricular support patient advance heart failure . Treatment patient population currently include lifestyle change , medicine , transcatheter intervention surgery , include implantation mechanical ventricular assist device ( VADs ) ; currently available VADs require highly invasive , high-risk surgical procedure implant due large device size , therefore generally limit use patient terminal heart failure . The Synergy pump intend treatment patient New York Heart Association ( NYHA ) Class III IV heart failure ; expect pump provide patient 2-3 L/min additional blood flow , give adequate cardiac support increase exercise tolerance improve patient ' quality life . The pump 's small size allow implant less surgically invasive procedure use previous VADs , result reduction perioperative morbidity . The device wil implant leave atrial subclavian artery bypass pump locate infraclavicular fossa like pacemaker .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Maximum tolerable medical therapy include ACE inhibitor Beta Blockers NYHA Class III IV despite maximal tolerable medical therapy Ambulatory ( inpatient outpatient ) Patients heart transplant list ( , currently list otherwise suitable heart transplant ) Life expectancy least 6 month without full VAD support Age &gt; 75 year Exercise tolerance limit factor heart failure Presence intraatrial thrombus Clinically significant right heart failure Serum creatinine &gt; /= 2.5 mg/dl dialysis previous 3 month Evidence intrinsic hepatic disease Previous episode resuscitate sudden death without subsequent treatment AICD Subclavian artery stenosis Low platelet count , INR correct prior implant contraindication anticoagulation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Partial Circulatory Assist</keyword>
	<keyword>NYHA Class IIIb</keyword>
	<keyword>NYHA Class IV</keyword>
	<keyword>Ventricular Assist Device</keyword>
	<keyword>VAD</keyword>
</DOC>